Download PDFPDF
Cohort study
Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address